Expression of tenascin-C and its isoforms in the breast
- 4 September 2010
- journal article
- review article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 29 (4) , 595-606
Abstract
Tenascin-C (TNC) is an extracellular matrix glycoprotein which is frequently up-regulated in a variety of pathological conditions including chronic inflammation and cancer. TNC has been implicated in the modulation of cell migration, proliferation, invasion and angiogenesis. Multiple isoforms of TNC can be generated through the alternative splicing of nine exons located in the fibronectin type III region of the molecule. The profile of isoforms expressed differs between cancers and normal breast, with the fully truncated TNC isoform being predominant in normal and benign tissues and higher molecular weight isoforms induced predominantly in cancer. The addition of extra domains within the fibronectin type III repeat domain greatly affects TNC function with multiple exon combinations available for splicing. Exons 14 and 16 are considered to be tumour-associated and have been shown to affect breast cell line invasion and growth in vitro to a greater extent than the full-length TNC isoform. This mini review will provide a summary of the literature to date regarding the expression of TNC isoforms in the breast and also discuss more recent developments in the field regarding exon AD1.Keywords
This publication has 111 references indexed in Scilit:
- Association of invasion-promoting tenascin-C additional domains with breast cancers in young womenBreast Cancer Research, 2010
- The role of tenascin-C in tissue injury and tumorigenesisJournal of Cell Communication and Signaling, 2009
- Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanismsBreast Cancer Research, 2009
- Gene expression profiling of the tumor microenvironment during breast cancer progressionBreast Cancer Research, 2009
- Microenvironmental regulation of metastasisNature Reviews Cancer, 2008
- Endogenous human microRNAs that suppress breast cancer metastasisNature, 2008
- Fibroblasts in cancerNature Reviews Cancer, 2006
- The Fibroblastic Coconspirator in Cancer ProgressionCold Spring Harbor Symposia on Quantitative Biology, 2005
- Enhanced tenascin-C expression and matrix deposition during Ras/TGF-β-induced progression of mammary tumor cellsOncogene, 2004
- Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progressionEuropean Journal of Cancer, 2002